BWT’s new pharmaceutical water system makes drug manufacturing safer

Published: 24-Sep-2013

Two types of LOOPO are available: cold water and hot water; plus four standard capacities of 3,000 to 23,000 litres per hour

The LOOPO pharma water distribution system, developed by BWT Pharma & Biotech in Germany, provides the highest standard of hygiene safety in the treatment of pure water, highly purified water (PW/HPW) and water for injection (WFI).

Pharmaceutical water produced from drinking water is used as a source material and excipient for pharmaceutical and biotechnology industry products such as cleaning and rinsing agents, for which statutory minimum physiochemical and microbiological standards apply, as specified by national pharmacopoeias and monographs.

Following the launch of its new generation of the Osmotron/Osmovision pharma water system, BWT Pharma & Biotech has now further developed the LOOPO range.

BWT LOOPO is a compact, standardised system for the distribution, sanitisation, control and monitoring of purified and highly purified water or water-for-injection circulation systems. It offers a reliable means of maintaining the quality benchmarks achieved in the water treatment process throughout the production process chain, right up to the finished product. The combination of BWT technologies and processes is said to provide a particularly high standard of hygiene, coupled with low operating costs and environmental benefits.

Two types of BWT LOOPO are available: cold water (LOOPO C), for purified and highly purified water (PW/HPW), and hot water (LOOPO H) for water for injection (WFI), plus four standard capacities of 3,000–23,000 litres per hour. Larger capacities for specific projects can also be accommodated.

In the LOOPO C variant, the storage tank, the area most vulnerable to germs, receives a constant supply of ozonated water from the integrated BWT Steritron ozone generation system for the prevention of microbial growth. The excess of any residual ozone is then reduced to below the detection limit of 5ppb upstream of the tapping points using BWT Bewades UV disinfection. This avoids extensive, costly sanitisation and sterilisation of the distribution systems and eliminates the need for increased investment in total isolation.

The firm says all of the systems are fully pre-tested and certified, and their ultra compact design means that they can be easily integrated into existing systems.

You may also like